Adalbert Krawczyk

4.2k total citations · 2 hit papers
75 papers, 2.4k citations indexed

About

Adalbert Krawczyk is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Adalbert Krawczyk has authored 75 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 26 papers in Infectious Diseases and 15 papers in Hepatology. Recurrent topics in Adalbert Krawczyk's work include SARS-CoV-2 and COVID-19 Research (24 papers), Herpesvirus Infections and Treatments (21 papers) and COVID-19 Clinical Research Studies (19 papers). Adalbert Krawczyk is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (24 papers), Herpesvirus Infections and Treatments (21 papers) and COVID-19 Clinical Research Studies (19 papers). Adalbert Krawczyk collaborates with scholars based in Germany, Moldova and United States. Adalbert Krawczyk's co-authors include Ulf Dittmer, Oliver Witzke, Christiane Silke Heilingloh, Eike Steinmann, Mira Alt, Monika Lindemann, Leonie Schipper, Lilia Cojuhari, Pavlina Jimbei and Valentin Cebotarescu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Gastroenterology.

In The Last Decade

Adalbert Krawczyk

71 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Susceptibility of SARS-CoV-2 to UV irradiation

2020 279 citations Christiane Silke Heilingloh, Ulrich Wilhelm Aufderhorst et al. profile →
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease

2021 139 citations Lukas van de Sand, Maren Bormann et al. Viruses profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adalbert Krawczyk Germany	25	942	933	508	301	273	75	2.4k
Jieliang Chen China	20	1.2k 1.2×	757 0.8×	808 1.6×	70 0.2×	558 2.0×	44	2.6k
Deborah R. Taylor United States	26	1.0k 1.1×	867 0.9×	1.1k 2.2×	294 1.0×	549 2.0×	39	3.4k
Annemarie Berger Germany	35	1.8k 1.9×	1.7k 1.9×	995 2.0×	125 0.4×	205 0.8×	130	3.7k
Ronald Dijkman Switzerland	31	969 1.0×	3.6k 3.8×	157 0.3×	379 1.3×	577 2.1×	73	4.9k
Yao Deng China	29	530 0.6×	1.5k 1.6×	131 0.3×	232 0.8×	442 1.6×	131	3.0k
Fei Yu China	26	862 0.9×	1.7k 1.8×	150 0.3×	67 0.2×	228 0.8×	83	2.8k
Mirko Trilling Germany	28	903 1.0×	903 1.0×	81 0.2×	241 0.8×	944 3.5×	94	3.0k
Robert Krause Austria	24	575 0.6×	625 0.7×	314 0.6×	147 0.5×	70 0.3×	105	2.3k
Nicasio Mancini Italy	31	1.2k 1.3×	1.1k 1.2×	467 0.9×	171 0.6×	458 1.7×	123	3.3k
Nicola Clementi Italy	26	650 0.7×	714 0.8×	208 0.4×	117 0.4×	411 1.5×	80	1.9k

Countries citing papers authored by Adalbert Krawczyk

Since Specialization

Citations

This map shows the geographic impact of Adalbert Krawczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adalbert Krawczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adalbert Krawczyk more than expected).

Fields of papers citing papers by Adalbert Krawczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adalbert Krawczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adalbert Krawczyk. The network helps show where Adalbert Krawczyk may publish in the future.

Co-authorship network of co-authors of Adalbert Krawczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Adalbert Krawczyk. A scholar is included among the top collaborators of Adalbert Krawczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adalbert Krawczyk. Adalbert Krawczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lindemann, Monika, Lukas van de Sand, Nils Mülling, et al.. (2024). Sequential Vaccination Against Streptococcus pneumoniae Appears as Immunologically Safe in Clinically Stable Kidney Transplant Recipients. Vaccines. 12(11). 1244–1244.

Korth, Johannes, Stefan Eßer, Christina B. Karsten, et al.. (2024). Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in People Living with HIV (PLWH). Vaccines. 12(7). 785–785. 4 indexed citations

Bormann, Maren, Mira Alt, Laura Thümmler, et al.. (2023). Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5. Frontiers in Immunology. 14. 1150667–1150667. 10 indexed citations

Alt, Mira, Lukas van de Sand, Robin Dittrich, et al.. (2023). Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study. Frontiers in Immunology. 14. 1143870–1143870. 1 indexed citations

Limmer, Andreas, Andrea Engler, Johannes Roth, et al.. (2023). Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease State. Vaccines. 11(2). 435–435. 5 indexed citations

Elsner, Carina, Margarethe Konik, Martina Broecker‐Preuss, et al.. (2023). False-Positive Screening and Confirmatory HIV Diagnostic Test in a Patient with Cured SARS-CoV-2 Infection Is Not Mediated by Env/Spike Cross-Reactive Antibodies. Viruses. 15(5). 1161–1161. 4 indexed citations

Jahn, Michael, Johannes Korth, Olympia E. Anastasiou, et al.. (2022). Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis. Vaccines. 10(2). 327–327. 5 indexed citations

Thümmler, Laura, Monika Lindemann, Peter A. Horn, et al.. (2022). Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients. Viruses. 15(1). 119–119. 7 indexed citations

Tödt, Daniel, Toni Luise Meister, Dajana Paulmann, et al.. (2021). A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes. iScience. 24(8). 102908–102908. 18 indexed citations

10.

Korth, Johannes, Benjamin Wilde, Sebastian Dolff, et al.. (2021). SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study. International Journal of Environmental Research and Public Health. 18(9). 4540–4540. 7 indexed citations

11.

Steinhauer, Katrin, Toni Luise Meister, Daniel Tödt, et al.. (2021). Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2. Journal of Hospital Infection. 112. 27–30. 15 indexed citations

12.

Ruzsics, Zsolt, Adalbert Krawczyk, Marek Widera, et al.. (2020). A Novel, Broad-Acting Peptide Inhibitor of Double-Stranded DNA Virus Gene Expression and Replication. Frontiers in Microbiology. 11. 601555–601555. 10 indexed citations

13.

Bazinet, Michel, Victor Pântea, Gheorghe Plăcintă, et al.. (2020). Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy. Gastroenterology. 158(8). 2180–2194. 162 indexed citations

14.

Aufderhorst, Ulrich Wilhelm, Mira Alt, Ulf Dittmer, et al.. (2018). Induction of herpes simplex virus type 1 cell-to-cell spread inhibiting antibodies by a calcium phosphate nanoparticle-based vaccine. Nanomedicine Nanotechnology Biology and Medicine. 16. 138–148. 11 indexed citations

15.

Korth, Johannes, Adalbert Krawczyk, Benjamin Wilde, et al.. (2018). T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients. Journal of Clinical Virology. 105. 91–96. 34 indexed citations

16.

Krawczyk, Adalbert, Rudolf Trenschel, Markus Ditschkowski, et al.. (2018). Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR. Journal of Clinical Virology. 99-100. 61–66. 27 indexed citations

17.

Bauer, Dirk, Mira Alt, Axel Schubert, et al.. (2017). Antibody-based immunotherapy of aciclovir resistant ocular herpes simplex virus infections. Virology. 512. 194–200. 10 indexed citations

18.

Krawczyk, Adalbert, Maren Kasper, Anna Buch, et al.. (2015). Prevention of Herpes Simplex Virus Induced Stromal Keratitis by a Glycoprotein B-Specific Monoclonal Antibody. PLoS ONE. 10(1). e0116800–e0116800. 21 indexed citations

19.

Krawczyk, Adalbert, Christoph Jochum, Melanie Fiedler, et al.. (2014). Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine. Vaccine. 32(39). 5077–5082. 47 indexed citations

20.

Klempa, Boris, Detlev H. Krüger, Brita Auste, et al.. (2009). A Novel Cardiotropic Murine Adenovirus Representing a Distinct Species of Mastadenoviruses. Journal of Virology. 83(11). 5749–5759. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact